SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-020506
Filing Date
2021-04-06
Accepted
2021-04-06 21:55:02
Documents
2
Period of Report
2021-04-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3318
2 POWER OF ATTORNEY ea139155ex24-1_cmlife3.htm EX-24.1 8170
  Complete submission text file 0001213900-21-020506.txt   12804
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences III Inc. (Issuer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173
SIC: 6770 Blank Checks

Mailing Address 667 MADISON AVENUE C/O CORVEX MANAGEMENT NEW YORK NY 10065
Business Address
Owusu-Kesse Kwame (Reporting) CIK: 0001854799 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40312 | Film No.: 21810516